PA Hospital lung cancer researcher Dr Arutha Kulasinghe has collaborated with local and overseas researchers to identify a genetic marker called IFI27 in the lung tissue and blood of people with Covid-19 which can be used to identify how severe the virus is likely to be in Covid-19 patients and signal whether they need to be hospitalised or are able to quarantine at home. Sydney-based company SpeeDx are now developing a blood test that could be used by an infected person, early on in their symptoms, as a guide to how bad their infection will be. | https://www.pafoundation.org.au/news/36/covid-19-studies-advanced-thanks-to-cancer-research
An experimental drug, molnupiravir, for severe Covid cuts the risk of hospitalisation or death by about half, according to initial clinical trial results.This potentially adds a new tool to our toolkit in our fighting against covid19.To find out more about this new pill and the study, click the link below:https://www.bbc.co.uk/news/health-58764440
Surprisingly, the COVID crisis has had a positive effect on education. It has forced us to rethink teaching methodologies and search for innovative ways to improve the quality and relevance of the education provided in schools and bring it up-to-date with modern technology tools.
Israel offers some well proven and innovative educational technologies that are applicable to schools’ colleges and vocational institutes. These unique learning technologies equip students with a set of skills and knowledge that help them to best fulfill their own innate potential and cope successfully with industrial changes and the disruption of Covid 19. For more: https://israeltrade.org.au/2021/10/08/israeli-education-technologies-redefining-education-in-the